MedPath

Comparison of serum and placental levels of an enzyme (angiotensin-converting enzyme)and a vasodilator (nitric oxide) in preeclampsia patients

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: O149- Unspecified pre-eclampsia
Registration Number
CTRI/2019/01/016890
Lead Sponsor
Kasturba Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Cases: Patients diagnosed with preeclampsia who are in their 3rd trimester of pregnancy

Controls: Healthy subjects in the 3rd trimester of pregnancy who do not exhibit symptoms of preeclampsia and gestational diabetes.

Exclusion Criteria

Pregnant subjects showing complications such as gestational diabetes, hypertension, etc are excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.